Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
15.58B | 14.18B | 13.02B | 12.34B | 10.99B | 11.51B | Gross Profit |
6.07B | 5.68B | 5.03B | 4.65B | 4.06B | 4.24B | EBIT |
511.04M | 869.71M | 1.04B | 876.85M | 478.83M | 520.13M | EBITDA |
759.22M | 1.08B | 1.15B | 1.55B | 630.63M | 1.06B | Net Income Common Stockholders |
133.38M | 680.12M | 1.11B | 1.01B | 151.08M | 411.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.38B | 5.83B | 5.87B | 5.30B | 3.37B | 3.37B | Total Assets |
10.62B | 11.89B | 9.95B | 8.94B | 6.99B | 7.41B | Total Debt |
1.14B | 1.50B | 829.71M | 924.05M | 575.64M | 802.73M | Net Debt |
-3.24B | -4.33B | -5.04B | -4.38B | -2.79B | -2.57B | Total Liabilities |
5.07B | 5.98B | 4.50B | 4.33B | 3.29B | 3.86B | Stockholders Equity |
4.40B | 4.77B | 4.30B | 3.47B | 2.75B | 2.69B |
Cash Flow | Free Cash Flow | ||||
233.04M | 983.65M | 1.15B | 1.78B | 372.50M | 1.85B | Operating Cash Flow |
388.31M | 1.18B | 1.43B | 1.93B | 558.50M | 1.99B | Investing Cash Flow |
14.14M | -915.92M | -331.46M | 42.25M | -136.84M | -256.00M | Financing Cash Flow |
-678.40M | -320.84M | -564.12M | -118.58M | -432.61M | -235.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥14.91B | 6.02 | 1.27% | 17.70% | 68.00% | ||
80 Outperform | ¥9.25B | 16.79 | 3.76% | 4.74% | 84.68% | ||
74 Outperform | ¥13.55B | 40.35 | 2.12% | 9.55% | -50.01% | ||
68 Neutral | ¥12.17B | 19.39 | 0.95% | -4.12% | 115.46% | ||
67 Neutral | ¥2.56B | 27.30 | ― | 12.50% | -20.45% | ||
61 Neutral | $14.74B | 5.90 | -4.02% | 6.40% | 2.72% | -31.67% | |
47 Neutral | ¥6.33B | ― | ― | 16.03% | -27.98% |